Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
BIOX 
Bioceres Crop Solutions Corp (BIOX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/23/2025: BIOX (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $3.75
1 Year Target Price $3.75
| 4 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -5.42% | Avg. Invested days 39 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/23/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 120.02M USD | Price to earnings Ratio - | 1Y Target Price 3.75 |
Price to earnings Ratio - | 1Y Target Price 3.75 | ||
Volume (30-day avg) 4 | Beta 0.33 | 52 Weeks Range 1.20 - 7.44 | Updated Date 10/24/2025 |
52 Weeks Range 1.20 - 7.44 | Updated Date 10/24/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.83 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -15.54% | Operating Margin (TTM) -20.3% |
Management Effectiveness
Return on Assets (TTM) 1.71% | Return on Equity (TTM) -15.9% |
Valuation
Trailing PE - | Forward PE 14.99 | Enterprise Value 312963577 | Price to Sales(TTM) 0.36 |
Enterprise Value 312963577 | Price to Sales(TTM) 0.36 | ||
Enterprise Value to Revenue 0.94 | Enterprise Value to EBITDA 17.98 | Shares Outstanding 60309910 | Shares Floating 37884056 |
Shares Outstanding 60309910 | Shares Floating 37884056 | ||
Percent Insiders 37.19 | Percent Institutions 32.05 |
Upturn AI SWOT
Bioceres Crop Solutions Corp
Company Overview
History and Background
Bioceres Crop Solutions Corp. was founded in 2001 in Argentina. Initially focused on agricultural biotechnology, it has evolved into a global provider of sustainable agricultural solutions, with significant milestones including the commercialization of HB4 drought tolerance technology.
Core Business Areas
- Seed and Integrated Products: Development and commercialization of proprietary seeds, seed treatments, and other integrated products focused on yield enhancement and stress tolerance.
- Biological Solutions: Development and commercialization of biological agricultural inputs, including biofertilizers, biopesticides, and other microbial solutions.
- Crop Nutrition: Development and sales of plant nutrition products. This includes micronutrients and macro-nutrients.
Leadership and Structure
Federico Trucco is the CEO. The company operates with a global management team and a board of directors.
Top Products and Market Share
Key Offerings
- HB4 Wheat: Drought-tolerant wheat variety. Market share is growing but not yet dominant; competitors include traditional wheat varieties and other drought-tolerant technologies. Revenue is expanding quickly.
- Biological Seed Treatments: Microbial seed treatments designed to improve crop establishment and yield. Growing market share. Competitors include Bayer CropScience, Syngenta.
- Biofertilizers: Bioceres develops and commercializes several biofertilizers products. The size of the biofertilizer market is growing quickly in Argentina. Competitors include Bayer CropScience, Syngenta, Novozymes.
Market Dynamics
Industry Overview
The agricultural inputs market is experiencing growth driven by the need for increased food production and sustainable agricultural practices. There's a growing demand for biological solutions and climate-smart agriculture.
Positioning
Bioceres is positioned as a leader in sustainable agricultural solutions, particularly in drought tolerance and biological inputs. Its competitive advantages include proprietary technology and a strong presence in South America.
Total Addressable Market (TAM)
The agricultural biologicals market is projected to reach tens of billions of dollars. Bioceres is well-positioned to capture a significant share of this TAM with its HB4 technology and other sustainable solutions.
Upturn SWOT Analysis
Strengths
- Proprietary HB4 technology
- Strong presence in South America
- Focus on sustainable agricultural solutions
- Experienced management team
- Diverse product portfolio
Weaknesses
- Relatively small size compared to major agrochemical companies
- Dependence on regulatory approvals
- Limited brand recognition in some markets
- Profitability challenges
- Geographic concentration (South America)
Opportunities
- Expanding into new geographic markets
- Increasing demand for sustainable agricultural practices
- Strategic partnerships with major agricultural companies
- Further development of HB4 technology
- Growth in biological inputs market
Threats
- Competition from major agrochemical companies
- Regulatory changes
- Commodity price volatility
- Climate change impacts
- Intellectual property infringement
Competitors and Market Share
Key Competitors
- BAYRY
- SYT
- NZYMF
Competitive Landscape
Bioceres faces competition from major agrochemical companies, but differentiates itself through its focus on sustainable agricultural solutions and proprietary technology.
Major Acquisitions
Rizobacter Argentina S.A.
- Year: 2016
- Acquisition Price (USD millions): 178
- Strategic Rationale: Enhanced its biological solutions portfolio and expanded its presence in the seed treatment market.
Marrone Bio Innovations
- Year: 2022
- Acquisition Price (USD millions): 236
- Strategic Rationale: Expanded its biological solutions portfolio
Growth Trajectory and Initiatives
Historical Growth: Bioceres has experienced significant revenue growth in recent years, driven by the commercialization of HB4 technology and the expansion of its product portfolio.
Future Projections: Analysts project continued revenue growth, driven by increasing adoption of sustainable agricultural practices. Profitability is expected to improve over time.
Recent Initiatives: Recent strategic initiatives include partnerships with major agricultural companies, expansion into new geographic markets, and further development of HB4 technology.
Summary
Bioceres is a growing agricultural solutions company with proprietary technology and a focus on sustainability. It has experienced significant revenue growth, but profitability remains a challenge. The company faces competition from major agrochemical companies but is well-positioned to capitalize on the increasing demand for sustainable agricultural practices and strategic partnerships.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings, Analyst reports, Industry publications
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Market conditions and company performance can change rapidly.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Bioceres Crop Solutions Corp
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2018-03-22 | Executive Chairman & CEO Dr. Federico Trucco Ph.D. | ||
Sector Basic Materials | Industry Agricultural Inputs | Full time employees - | |
Full time employees - | |||
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.